Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Clinical trial NCT04553757 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04553757
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-08
- Primary completion
- 2027-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.